Keith Delman

melanoma surgeon, surgical educator, father, husband and fisherman

[Society of Surgical Oncology @SocSurgOnc]

New weekly @AnnSurgOncol featured article: Short-term Patient-Reported Outcomes Following Bilateral Risk-Reducing Mastectomy for Patients at a High Risk for Breast Cancer: A Systematic Review. 

https://t.co/jH7eRB53Ou #ASOFeaturedArticle

[Emory Surgery @EmorySurgery]

👏👏👏

[Annals of Surgical Oncology @AnnSurgOncol]

#AudioVisualAbstract : Results of a Randomized Clinical Study of #Gemcitabine Plus Nab-Paclitaxel Versus Gemcitabine Plus S-1 as Neoadjuvant Chemotherapy for Resectable and Borderline Resectable #Pancreatic #DuctalAdenocarcinoma

https://t.co/BVWhIS9owU

@SyedAAhmad5

[Annals of Surgical Oncology @AnnSurgOncol]

May Issue: Identification of Predictive Factors for the Development of In-Transit Metastasis in Patients with #Melanoma . @OlofssonBagge @C_ODonoghueMD @alabama_surgonc @MarkFariesMD @jzager99

https://t.co/R0NVlvQR9k

@DorianGarciaMD
@SyedAAhmad5

[Annals of Surgical Oncology @AnnSurgOncol]

#AudioVisualAbstract : Implementation of the Targeted Axillary Dissection Procedure in Clinically Node-Positive #BreastCancer : A Retrospective Analysis

https://t.co/h8ON20TaOP

@belenmerck
@SyedAAhmad5

[Annals of Surgical Oncology @AnnSurgOncol]

May Issue: Clinical Significance of Coiled-Coil Domain-Containing Protein 25 Expression in #Esophageal #SquamousCellCarcinoma

https://t.co/qFxJizsYZA

@lindSLUe
@SyedAAhmad5

[Annals of Surgical Oncology @AnnSurgOncol]

Featured: Strategies for Recurrent #ColorectalLiver Metastases Based on Prognostic Factors and Resectability: Potential Benefit of #MultidisciplinaryTreatment . @Kosuke_Koba_yh8

https://t.co/6Fp4kTNXTb

@_BrainyMD_
@SyedAAhmad5

[Annals of Surgical Oncology @AnnSurgOncol]

#AudioVisualAbstract : Endoscopic Evaluation of #PathologicalCompleteResponse Using #DeepNeuralNetwork in #EsophagealCancer Patients Who Received Neoadjuvant Chemotherapy—Multicenter Retrospective Study from Four Japanese Esophageal Centers

https://t.co/qsm3uK27Kk

@SyedAAhmad5

[Mass General Surgery @MGHSurgery]

Thank you for your excellent talks and for sharing your experiences with our residents in rocking chair rounds!

[Emory SOM at Grady Hospital @EmoryatGrady]

Join us on April 22, 2025, for the Emory at Grady Faculty Awards. This ceremony will recognize outstanding faculty contributions and achievements. Hope to see you there!279

[Annals of Surgical Oncology @AnnSurgOncol]

April Issue: Risk-Prediction Models for Clinical Decision-Making in #Sarcoma Care: An International Survey Among Soft-Tissue Sarcoma Clinicians @lvanbodegomvos

https://t.co/201tcnnAeI

@DorianGarciaMD
@SyedAAhmad5

[Keith Delman @KeithDelman]

.⁦@EmoryMedicine⁩ ⁦@EmoryatGrady⁩ ⁦@emorygradydoc⁩ ⁦@grannysurgeon⁩ ⁦@EmorySurgery⁩ This year’s SURG-20 class. Notice something special? Yep! All women. Truly an honor to teach these amazing future doctors ⁦@wiserpodcast⁩

[Society of Surgical Oncology @SocSurgOnc]

The latest SSO consensus statement urges caution with gene expression profiling (GEP) for primary cutaneous melanoma. Given evolving evidence, GEP is recommended as an investigational tool in research or clinical trials. Read more: @AnnSurgOncol: https://t.co/XxfMgcNeTL

[Callisia Clarke MD @DrCNClarke]

I get asked how GEP tests should be used in cutaneous melanoma at every meeting. Great to see this consensus statement out in print. @SocSurgOnc

[Keith Delman @KeithDelman]

Flying home to #ATL from “the City” that still holds a special place in my heart. #NYC (and always will)

[Society of Surgical Oncology @SocSurgOnc]

SSO announces publication of its 1st consensus statement, Assessing the Evidence For and Utility of Gene Expression Profiling of Primary Cutaneous Melanoma. Developed by melanoma specialists around four clinical questions on GEP testing for primary CM. https://t.co/QQgvP7cIKu

[Keith Delman @KeithDelman]

.⁦@EmoryMedicine⁩ ⁦@WinshipAtEmory⁩ ⁦@GradyHealth⁩ ⁦@emorygradydoc⁩ Marti Russell debating Dr. Jordan Berlin pros and cons of neoadjuvant therapy for pancreas cancer making us proud!! #DDHO2024

[Journal of Surgical Research @JSurgRes]

We are pleased to announce that Oliver Eng, MD, has been selected to serve as new Associate Editor for the Gastrointestinal Surgery section of JSR. Dr. Eng is an Associate Professor of Clinical Surgery in the Division of Surgical Oncology @UCIrvineSurgery.

[Timothy M. Pawlik @timpawlik]

Best job in the 🌎🌍🌏….being a dad to these great kids. Happy #FathersDay2024 to all the dads out there. Hug them twice as hard today! #BlessedAndGrateful

[Elizabeth Hechenbleikner, MD @EHechenbleikner]

Enjoyed celebrating our wonderful Emory General Surgery Chief Residents graduate last night with my friend and mentor @aa_chahine Congrats to all!! @EmorySurgery @EdLinEmory @emorygradydoc @falco__e @JsharmaSharma